133 related articles for article (PubMed ID: 36802727)
1. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p.
Hou J; Wang L; Wu Q; Zheng G; Long H; Wu H; Zhou C; Guo T; Zhong T; Wang L; Chen X; Wang T
Stem Cell Res Ther; 2018 Apr; 9(1):109. PubMed ID: 29673400
[TBL] [Abstract][Full Text] [Related]
3. LncRNA H19 Promotes Cell Proliferation, Migration, and Angiogenesis of Glioma by Regulating Wnt5a/β-Catenin Pathway via Targeting miR-342.
Zhou Q; Liu ZZ; Wu H; Kuang WL
Cell Mol Neurobiol; 2022 May; 42(4):1065-1077. PubMed ID: 33161527
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer.
Xia T; Liao Q; Jiang X; Shao Y; Xiao B; Xi Y; Guo J
Sci Rep; 2014 Aug; 4():6088. PubMed ID: 25124853
[TBL] [Abstract][Full Text] [Related]
5. Glycolysis reprogramming in cancer-associated fibroblasts promotes the growth of oral cancer through the lncRNA H19/miR-675-5p/PFKFB3 signaling pathway.
Yang J; Shi X; Yang M; Luo J; Gao Q; Wang X; Wu Y; Tian Y; Wu F; Zhou H
Int J Oral Sci; 2021 Mar; 13(1):12. PubMed ID: 33762576
[TBL] [Abstract][Full Text] [Related]
6. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
Li CF; Li YC; Wang Y; Sun LB
Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
[TBL] [Abstract][Full Text] [Related]
8. LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis.
Liu ZZ; Tian YF; Wu H; Ouyang SY; Kuang WL
Neoplasma; 2020 Jan; 67(1):111-118. PubMed ID: 31777264
[TBL] [Abstract][Full Text] [Related]
9. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3.
Liu L; Liu L; Lu S
Int J Oncol; 2019 Mar; 54(3):929-941. PubMed ID: 30747209
[TBL] [Abstract][Full Text] [Related]
10. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
11. The miRNA hsa-miR-6515-3p potentially contributes to lncRNA H19-mediated-lung cancer metastasis.
Xu Y; Lin J; Jin Y; Chen M; Zheng H; Feng J
J Cell Biochem; 2019 Oct; 120(10):17413-17421. PubMed ID: 31131469
[TBL] [Abstract][Full Text] [Related]
12. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
[TBL] [Abstract][Full Text] [Related]
13. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
[TBL] [Abstract][Full Text] [Related]
14. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
[TBL] [Abstract][Full Text] [Related]
15. The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP.
Zhao H; Peng R; Liu Q; Liu D; Du P; Yuan J; Peng G; Liao Y
Arch Biochem Biophys; 2016 Nov; 610():1-7. PubMed ID: 27693036
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma.
Guan GF; Zhang DJ; Wen LJ; Xin D; Liu Y; Yu DJ; Su K; Zhu L; Guo YY; Wang K
Int J Med Sci; 2016; 13(12):914-922. PubMed ID: 27994496
[TBL] [Abstract][Full Text] [Related]
17. LncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumor growth through its derivative miR-675.
Zhang T; Wang YR; Zeng F; Cao HY; Zhou HD; Wang YJ
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4891-4897. PubMed ID: 27981546
[TBL] [Abstract][Full Text] [Related]
18. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
J Biomed Sci; 2018 Feb; 25(1):11. PubMed ID: 29415742
[TBL] [Abstract][Full Text] [Related]
19. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
